20-F: Zhongchao Inc. Files 20-F, Details Financials and Corporate Governance

Zhongchao Inc. files its annual report on Form 20-F, providing insights into its financial performance, corporate structure, and risk factors for the year ended December 31, 2023.

Summary

• Zhongchao Inc., a Cayman Islands-based holding company, has filed its Form 20-F for the year ended December 31, 2023.
• The company consolidates the financial results of its PRC operating entities through VIE agreements.
• As of December 31, 2023, the company had 2,054,943 Class A Ordinary Shares and 549,772 Class B Ordinary Shares outstanding.
• A 1-for-10 share consolidation was effectuated on February 29, 2024.
• For the year ended December 31, 2023, revenues were $19,433,945 and net loss was $(11,307,239).
• The company identified material weaknesses in its internal control over financial reporting.
• The company adopted a clawback policy to recover erroneously awarded incentive-based compensation from executive officers.

Sentiment

Score: 4

Explanation: The document presents a mixed picture, with revenue growth offset by significant losses and internal control weaknesses. The company faces regulatory and competitive challenges, contributing to a cautious sentiment.

Positives

• Revenue increased by 37.3% from 2022 to 2023, driven by growth in patented drug sales.
• The company has established a comprehensive security management system in reference to ISO 27001.

Negatives

• The company reported a significant net loss of $11.31 million for the year ended December 31, 2023.
• Material weaknesses were identified in the company's internal control over financial reporting.
• The company recognized impairment losses on goodwill and intangible assets related to the West Angel acquisition.

Risks

• The company's VIE structure is subject to regulatory risks in China.
• Uncertainties exist regarding the interpretation and application of PRC laws and regulations.
• The company faces intense competition in the healthcare information and training services market.
• The company depends on the healthcare industry for a significant portion of its revenues.
• The company may be liable for improper use or appropriation of personal information provided by customers.
• The company may need additional capital and any failure to raise additional capital on terms favorable to us, or at all, could limit the PRC operating entities ability to grow their business and develop or enhance their service offerings to respond to market demand or competitive challenges.

Future Outlook

The company intends to continue its expansion in the foreseeable future to pursue existing and potential market opportunities.

Industry Context

The company operates in the competitive healthcare information, education, and training services market in China, facing competition from both onshore and offshore companies.

Corporate Governance

Related Party Transactions

• The company engaged in transactions with a company controlled by an immediate family member of the CEO.

Stakeholder Impact

• Shareholders face risks related to the company's VIE structure, regulatory uncertainties, and potential delisting.
• Employees may be affected by changes in compensation policies and internal control measures.
• Customers may benefit from the company's efforts to improve its online platform and expand its service offerings.

Next Steps

• The company will continue to implement measures to remediate the material weaknesses in internal control.
• The company will continue to upgrade their technology infrastructure to effectively meet demand for their services.

Key Dates

Keywords

financial results, VIE structure, risk factors, internal control, Zhongchao Inc, corporate governance, share consolidation, clawback policy